Propensity score matching is commonly used to draw causal inference from observational survival data. However, there is no gold standard approach to analyze survival data after propensity score matching, and variance estimation after matching is open to debate. We derive the statistical properties of the propensity score matching estimator of the marginal causal hazard ratio based on matching with replacement and a fixed number of matches. We also propose a double-resampling technique for variance estimation that takes into account the uncertainty due to propensity score estimation prior to matching.
Introduction
For observational survival data, Cox proportional hazards modeling is the most common approach to infer the association between treatment and survival outcome (Cox; 1972) . Following Rubin's causal model, Hernán et al. (2000) and Robins et al. (2000) proposed the marginal structural Cox proportional hazards model and inverse probability of treatment weighting to estimate the causal effect of treatment on survival outcome.
Under the classical assumptions of no unmeasured confounding and positivity, the causal effect of treatment is identifiable from the observed data. The seminal paper Rosenbaum and Rubin (1983a) has demonstrated the central role of propensity score as the balancing score, in the sense that balancing the propensity score can balance the observed covariates on average. Researchers have proposed regression, propensity score-based weighting, stratification, or matching estimators to adjust for confounding. In the context of survival analyses, Chen and Tsiatis (2001) proposed a regression model approach to estimate the average causal effect of restricted mean survival times. Xie and Liu (2005) developed the adjusted Kaplan-Merier estimators of treatment-specific survival functions using inverse probability weighting. Stürmer et al. (2005) demonstrated that different strategies are comparable to adjust for confounding for estimating hazard ratios including inverse probability weighting, propensity score matching, and stratification for a given dataset. Zhang and Schaubel (2012) combined Chen and Tsiatis (2001) 's regression method and the inverse probability weighted Nelson-Aalen estimator resulting in a doubly robust estimator of the average causal effect of restricted mean survival times. Tchetgen and Robins (2012) also proposed inverse probability weighting and doubly robust methods for the causal hazard ratio.
The regression adjustment is susceptible to bias due to model misspecification; while inverse probability weighting methods are unstable when the propensity score is close to zero or one. Matching methods have been demonstrated to overcome these drawbacks and present many practical advantages Stuart; 2010) . Therefore, matching is widely used in observational survival studies 2007 , 2008 . However, there is no gold standard approach to analyze survival data after propensity score matching with replacement, and variance estimation is open to debate. Gayat et al. (2012) used the Cox proportional hazards model and the robust variance estimator to infer the causal hazard ratio accounting for the matched pairs. Therneau and Grambsch (2013) suggested fitting the Cox proportional hazards model stratifying by the matched pairs. However, Austin (2013) pointed out that this strategy may give biased results for the marginal hazard ratio due to non-collapsibility. On the other hand, ignoring the matched nature is inappropriate 2014) . More importantly, in practice, the propensity scores are usually estimated through a parametric model in the first stage. Existing methods rarely incorporate the uncertainty prior to or in the matching stage and restrict inference to the matched sample.
In this article, we consider propensity score matching for causal inference in the context of survival analysis with two treatments. We focus on estimating the population average causal hazard ratio, which is arguably the parameter of most interest given the widespread use of the Cox model in practice. We note that paired matching may result in discarding data when the numbers of treated and control individuals are not equal. Following Abadie and Imbens (2006) , we use propensity score matching as a tool for imputing unobserved potential outcomes, i.e. counter-factual outcomes, for all individuals. Following most empirical literature, we use a logistic regression model to estimate the propensity score function. Because the propensity score function is estimated prior to matching, it is necessary to account for the uncertainty due to parameter estimation. Due to the non-smooth nature of matching, our derivation is based on the technique developed by Andreou and Werker (2012) , which offers a general approach for deriving the limiting distribution of statistics that involve estimated nuisance parameters. This technique has been successfully used in Abadie and Imbens (2016) for the matching estimators of the average causal effects in a continuous outcome context. We extend their results to the matching estimator in the survival outcome context. This extension is not trivial, because the survival outcome is often right censored. We utilize the martingale theory (Hall and Heyde; 1980) of the counting process to establish the asymptotic distribution of the propensity score matching estimator of the causal hazard ratio.
Lack of smoothness also makes the conventional replication methods invalid for variance estimation for the propensity score matching estimator. The bootstrap method (Efron; 1979) is a commonly used resampling approach that permits estimation of the sampling variability of estimated parameters. There is some controversy surrounding variance estimation when estimating treatment effects in propensity score matched samples. Abadie and Imbens (2008) demonstrated the failure of the bootstrap variance estimator for two-treatment matching with replacement and a fixed number of matches. The main reason is that the bootstrap sample does not preserve the distribution for the number of times that each individual is used as a match. Yet, Austin and Small (2014) demonstrated by simulation that the bootstrap has a good coverage property based on propensity score matching without replacement. Adusumilli (2017) recently proposed a bootstrap inference for the propensity score matching estimator for the continuous outcome, which improves the variance estimator based on the asymptotic distribution described by Abadie and Imbens (2016) . Accordingly, we propose a new replication-based inference for the propensity score matching estimator in the survival outcome context. Simulation demonstrates that the replication-based inference outperforms Wald-type inference based on the asymptotic theory in finite samples.
Notation, Models and Assumptions

Potential outcomes
We use the potential outcomes framework 1974) . We assume that the individuals are random samples from a larger population. Let X ∈ R d be a vector of baseline covariates. Let W denote the treatment, which takes value in {0, 1}. Let T (ω) denote the potential time to a clinical event had the individual received treatment ω. Let C (ω) be the time to censoring had the individual received treatment ω. We assume non-informative censoring under which C (ω) ⊥ ⊥ W, T (ω) | X, where ⊥ ⊥ means "independent of". The full set of variables is F = (X, W,
Marginal structural Cox proportional hazards model
For comparing two treatments, we consider the ideal case where we can observe F for each individual. We define the causal parameter
as the hazard rate of failing at time t for a population of patients had they received treatment ω. We define
) to be the time to a clinical event or censoring and the clinical event indicator, respectively, for an individual received treatment ω. We also define the counting process N (ω) (t) = I(U (ω) ≤ t, ∆ (ω) = 1) and the at-risk process Y (ω) (t) = I(U (ω) ≥ t). Following Tchetgen and Robins (2012) , we assume a causal Cox proportional hazards model.
Definition 1 (Causal Cox Proportional Hazards Model). The structural model for comparing treatments is
where λ 0 (t) is the population hazard rate if all individuals had treatment ω = 0.
This is a causal model, because it compares the outcome under different treatments in the same group of individuals, i.e., the population of all individuals. The parameter β describes the relative hazard of having a clinical event if all individuals received treatment ω = 1 compared to if all individuals received treatment ω = 0.
Observed data and the no unmeasured confounding assumption
The observed data are summarized as
. . , n, where X i is a vector of baseline covariates, W i is the actual treatment, T i is the time to a clinical event, C i is the observed censoring time, U i is the time to a clinical event or censoring, ∆ i is the clinical event indicator, We now define the observed data counting process as N i (t) = I(U i ≤ t, ∆ i = 1) and the at-risk process as Y i (t) = I(U i ≥ t). Let e(X i ) = P (W i = 1|X i ) be the propensity score for individual i to receive treatment ω = 1.
We make the consistency assumption that links the observed data processes with the potential outcome processes.
In order to use the distribution of the observed data to estimate the parameters in Model (1), we require the assumptions of unconfoundedness (also known as no unmeasured confounding or treatment ignorability) and positivity (Robins; .
Assumption 3 (Positivity). There exist positive constants c andc such that with probability 1, 0 < c < e(X i ) <c < 1.
Matching
If we were to observe all potential outcome processes, we can fit a Cox proportional hazards model to the data {N 
. . , n} to obtain an estimator for the causal log hazard ratio β 0 . However, the fundamental problem in the potential outcome framework is that we can observe for a particular individual i, {N (t)} with either ω = 0 or ω = 1 but never both. From this point of view, causal inference is inherently a missing data problem.
We use matching as a tool to impute the missing potential outcomes. We consider matching with replacement with the number of matches fixed at one, ignoring ties. To be precise, for individual i, the potential outcome process under W i is the observed outcome process (U i , ∆ i ) ; the potential outcome process under 1 − W i is not observed but can be imputed by the observed outcome process of the nearest individual with 1 − W i . Table 1 : Imputed data structure: k i is the number of times individual i is used as a match.
We first consider the case when the propensity score is known and matching is done based on the true propensity score. Define the propensity score matching function m(ω, p) as the index of the individual with treatment level ω that is closest to p in terms of the propensity score values m(ω, p) = arg min
Without loss of generality, we use the Euclidean distance to determine neighbors; the discussion applies to other distances 2006) . Define the imputed potential outcome as
or equivalently the imputed potential outcome process as
for ω = 0, 1. Table 1 presents the full imputed dataset. Let k i (W i ) be the number of times that individual i is used as a match for the opposite treatment group. Then, the full imputed dataset can be equivalently represented by a weighted observed dataset, where each individual i is assigned with a weight 1 + k i (W i ), 1 is the weight for individual i, and k i (W i ) is the weight individual i can represent for individuals in the opposite treatment group.
Estimating equations
Define Λ 0 (t) = t 0 λ 0 (v)dv as the cumulative hazard function at time t. In what follows, we derive our estimators for β 0 and Λ 0 (t), t ≥ 0.
Based on the imputed dataset, the estimating functions for β 0 and Λ 0 (t), t ≥ 0 are
where
We can also write (4) and (5) as
Setting (6) equal to zero, we can obtain the estimator for dΛ 0 (t) for fixed β as
Substituting (8) into (7), we obtain the estimating equation to solve for β. Let
then β is the solution to the estimating equation
which is the partial score equation for a proportional hazards model with W i as the covariate and weights 1 + k i (W i ) for each individual i. Therefore, β can be calculated by standard software.
To present the asymptotic properties of β, we introduce more notation.
We show in the supplementary material that under regularity conditions Q(β 0 , t) converges in probability to
uniformly over t ∈ [0, τ ] and that
Based on (13), we derive the asymptotic results for β.
Theorem 1. Under the regularity conditions presented in the supplementary material, with the known propensity score,
and
In observational data, the propensity score is often unknown and therefore has to be estimated from the observed data. Following most of the empirical literature, we assume that the propensity score follows a generalized linear model, e(X T i θ). We can then obtain a consistent estimateθ. The matching procedure can be carried out with the estimated propensity score e(X T iθ ). We now denote k i (ω) to be kθ ,i (ω) to reflect its dependence on the estimateθ.
To summarize, the algorithm for developing a matching estimator for β 0 when the propensity score is unknown is the following.
Step 1. Using the data {(X i , W i ) : i = 1, . . . , n}, fit a propensity score model, e.g. a logistic
regression model e(X T i θ) and obtain an estimateθ.
Step 2. Based on the estimated propensity scores, create an imputed dataset as in Table 1 , where the missing potential outcomes are imputed using the nearest neighbor imputation.
Step 3. Create weights for each individual i as 1 + kθ ,i (W i ), where kθ ,i (W i ) be the number of times that individual i is used as a match for the opposite treatment group based on the estimated propensity score estimates.
Step 4. Obtain estimator for β 0 by solving (10) using the standard software; e.g., the function "coxph" in R with the weighting argument.
We study the asymptotic properties of the estimator in the case when the matching variable is the estimated propensity score. The technique we will use is based on Andreou and Werker (2012) , who proposed a unified approach to study the limiting distribution of statistics with estimated nuisance parameters. This technique has been applied by Abadie and Imbens (2016) to study the asymptotic distribution of the matching estimator based on estimated propensity score in the context of causal inference.
Theorem 2. Under the regularity conditions presented in the supplementary material, with the estimated propensity score,
Theorem 2 shows that matching based on the estimated propensity score improves the efficiency of the matching estimator compared to matching based on the true propensity score if it is known. This phenomenon is in line with that in the setting with a continuous come .
Theorem 2 provides variance estimation based on approximation of the asymptotic variance formula. See the supplementary material. In the next section, we propose re-sampling variance estimation that has a better finite-sample performance. Abadie and Imbens (2008) demonstrated that the nonparametric bootstrap is invalid for the matching estimator based on matching with replacement and with a fixed number of matches. Otsu and Rai (2017) suggested resampling the matching estimator directly based on its martingale residual terms, which only works for matching based on the full vector of covariates. In order to reflect the uncertainty in the estimation of the propensity score, Adusumilli (2017) proposed a hybrid bootstrap procedure by resampling treatment variables and resampling the martingale residuals under both treatment conditions. This necessitates imputation of the unobserved martingale residuals under the opposite treatment. We define the martingale residuals as
Resampling based inference
where µ H (ω, p) is obtained by a non-parametric regression estimation of H i on e(X T i θ) among individuals with W i = ω. We propose a double-resampling procedure as follows.
Step 0. For individual i, find the secondary nearest neighbor matching function m(ω, X i );
if W i = ω, m(ω, X i ) = i, otherwise, m(ω, X i ) returns the index of the nearest neighbor in the opposite treatment group, matching based on the full X, rather than on the propensity score. The pair of potential residuals for individual i are
Moreover, we need to estimate the matching function
we use the following imputation strategy: create quintiles based on e(X T i θ), identify the quintile individual i falls, randomly sample one, say l, from that quintile with W j = ω, and let k i (ω) = k θ,l .
Step 1. Generate the bootstrap treatment, W * i , i = 1, . . . , n, from W * i = 0, with probability 1 − e(X T iθ ), 1, with probability e(X T iθ ).
Step 2. Based on
, re-fit the propensity score model and obtain the replicate θ * .
Step 3. Generate a sequence of independent and identically distributed random variables
, with probability
Step 4. Define the new bootstrap residuals as
whose expectation over the probability distribution implied by Step 1, conditional on the original data, is
where k θ,i (ω) is imputed at Step 0. Re-center the bootstrap residuals and compute the
Step 5. Repeat Steps 1-4 for a large number B times and denote the bth replicate of S n (β 0 ) as S * (b) n . Construct the (1 − α)% percentile bootstrap confidence interval for S n (β 0 ) as S * n(α/2) , S * n(1−α/2) , where S * nq is the qth percentile of {S * (1) n , . . . , S * (B) n }.
We construct the (1 − α)% confidence interval for β 0 as ∂S n ( β)/∂β −1 S * n(α/2) , S * n(1−α/2) . Remark. Here we provide some discussion to Step 0. Note that the secondary matching procedure matches on the full set of covariates, rather than on the propensity scores. Doing so preserves the conditional covariance in (16) between X and the error terms r 2i , given the propensity scores. This term reflects the improvement when using the estimated propensity score. See Adusumilli (2017) . We impute k i (ω) by drawing a value from the empirical distribution of k i (W i ) in propensity score strata for W i = ω to re-create the distribution of k i (W i ).
Simulation
We conduct simulation studies to assess the finite sample performance of the proposed estimators relative to existing estimators: (i) the unadjusted estimatorβ nai , which is obtained by fitting the Cox proportional hazards model with the treatment status as the only covariate and therefore is used to demonstrate the degree of confounding bias;
(ii) the inverse probability weighting estimatorβ ipw , where a weighted Cox proportional hazards model was fitted with the treatment status as the only covariate, weighted by the inverse of the probability of the actual treatment; (iii) the regression estimatorβ reg , where the Cox proportional hazards model was fitted with baseline covariates and treatment status as the covariates; (iv) the propensity score matching estimatorβ psm,0 based on the true propensity score; (v) the proposed propensity score matching estimatorβ psm based on estimated propensity score.
These comparative estimators have been widely used in practice, which motivates us to compare these estimators in our simulation study. For variance estimation ofβ nai ,β ipw , andβ reg , we consider the robust output from the standard software, denoted byV nai ,V ipw , andV reg . For inference based onβ psm , we construct Wald confidence interval based on the empirical variance estimator and two bootstrap percentile confidence intervals with the conventional bootstrap and the proposed double-resampling procedure.
We consider a sample size of n = 1000. Let X i = (X 1i , X 2i ) be a vector of baseline covariates, where we generate X ki from exponential distribution with mean 1/λ k with λ k = 1 for k = 1 and 2. We generate the treatment indicator W i ∼Ber(p i ), where
. We generate two potential outcomes T (0) i and T
(1) i according to Algorithm S1 that are compatible with Model (1). The observed time to event is
We also generate the time to censoring C i from a uniform distribution, so that 20% to 30% of the event time is censored.
We consider simulation scenarios formed by crossing the following two factors:
1) degree of confounding ranging from weak, medium and strong by considering θ = (θ 0 , θ 2) model specification of the propensity score model: Scenario (i) using a correct specification of the propensity score model; i.e., a logistic regression model with the linear predictor θ 0 + θ T 1 X i , and Scenario (ii) using a misspecification of the propensity score model; i.e., a logistic regression model with the linear predictor θ 0 + θ Table 2 shows the results when true β 0 = 0. The results for β 0 = −0.5 and β 0 = 0.5 are presented in the supplementary material. The unadjusted estimatorβ nai has severe bias and thus barely captures β 0 , which becomes worse for stronger separation of propensity scores between treatment groups. The inverse probability weighting estimatorβ ipw greatly reduces the bias; however, its variability is underestimated when two treatment groups are strongly separated in propensity scores and the propensity score model is correctly specified, thus the robust confidence interval from the standard software has some undercoverage issue in this case. The bias of the regression estimatorβ reg is always much larger than the propensity score based estimators. For all investigated simulation scenarios,β psm possesses the smallest bias and best coverage rate of 95% confidence intervals using the proposed asymptotic variance estimation and double-resampling variance estimation, among all estimators under comparison. On the other hand, using the standard software's robust method always overestimates the variances ofβ psm,0 andβ psm . Thus, our newly proposed variance estimation approaches is apparently beneficial for making reliable inference. Simulations with a sample size of n = 200 are included in the supplementary material. For the small sample cases, it is noticed that the double-resampling method recovers the 95% confidence level better than the asymptotic method.
An application
Non-small cell lung cancer (NSCLC) is the most commonly diagnosed lung cancer; typically, around half the NSCLC patients receiving chemotherapy will receive additional treatment in the post progression setting, i.e. second-line treatment setting, where "carboplatin + paclitaxel" and "erlotinib" are two historically commonly used treatments; see Cui et al. (2018) . In this section, we use the IMS Health Oncology electronic medical record (EMR) -0.2 9.6 10.9 96.6 -0.5 10.2 11.9 96.7 -0.7 11.7 14.2 96.8 β psm software -0.3 9.5 10.8 96.6 -0.6 9.8 11.7 96.8 -0.4 11.2 13.9 96.3 asymp -0.3 9.5 9.2 94.6 -0.6 9.8 9.8 94.7 -0.4 11.2 10.9 93.3 naiveboot -0.3 9.5 8.9 97.3 -0.6 9.8 9.2 96.8 -0.4 11.2 10.1 95.8 double-rsp -0.3 9.5 10.3 96.0 -0.6 9.8 11.7 96.5 -0.4 11.2 13.9 95.5
Note: "Var" is the variance of point estimates of β 0 across simulated datasets; "VE" is the average variance estimation for the point estimators over simulations, thus VE minus Var reflects the bias in estimated variance; "CR" is the empirical coverage rate of 95% confidence intervals. Four types of variance estimates forβ psm were compared: "software", output from the standard software; "asymp", the proposed asymptotic variance estimation; "naiveboot", the naive nonparametric bootstrap; "double-rsp", the proposed double-resampling method. data to conduct a comparative effectiveness analysis of the two treatments in the secondline setting with the proposed causal inference of hazard ratio based on propensity score matching estimator and other existing estimators mentioned in the previous section.
The EMR data is deidentified observational patient-level clinical data with demographic and baseline clinical characteristics collected from medium and large community-based oncology practices across 50 states of the USA. The dataset used contains retrospective cohort of 10,634 eligible patients at least 18 years old who received at least two lines of therapy, from 1 January 2007 to 31 December 2014; see Cui et al. (2018) for details. The time from the start date of second-line therapy to the death date was defined as overall survival. Patients alive at the end of the time period were censored at the end date of the dataset, and patients with the time between last visit and the end of dataset shorter than a sufficient time were censored at the date of last visit, where sufficient time is defined as twice the average time between visits in 3 month before the last visit. Missing data were classified into its own category for each categorical variable; see de Rooij (2018) . Among the eligible patients in the dataset, 1241 patients were treated with carboplatin + paclitaxel, and 895 patients received single-agent erlotinib as second-line therapy.
The propensity scores were estimated using a logistic regression model with predictors: age at initiation of second-line therapy, gender, race, region, disease stage at initial diagnosis, Eastern Cooperative Oncology Group performance status score at initiation of second-line therapy, facility types of academic or community cancer center, year of index diagnosis, and days from index diagnosis to initiation of second-line therapy, see Cui et al. (2018) for details. To improve the overlapping in the covariate distribution for more credible matching, see Yang et al. (2016) , we applied Crump et al. (2009) 's trimming method to drop patients with extremely high or low propensity scores, the remaining sample contains 1027 patients receiving carboplatin + paclitaxel and 872 patients receiving erlotinib. We proceed with the data of the remaining patients in the two cohorts for comparative effectiveness analysis on the population represented after trimming. Table 3 shows estimated log hazard ratioβ, point estimates and 95% confidence intervals for the hazard ratio of "carboplatin + paclitaxel" to "erlotinib" based on the unadjusted estimatorβ nai , the inverse probability weighting estimatorβ ipw , the regression estimatorβ reg with the robust variance estimation from the standard software for constructing Wald confidence intervals. For the proposed inference based on propensity score matching estimatorβ psm , we constructed both Wald confidence interval based on the empirical asymptotic variance estimator and bootstrap percentile confidence interval with the proposed double-resampling method. All adjusted methods gave higher hazard ratio estimates than the unadjusted naive method. The propensity score matching approach estimated that "carboplatin + paclitaxel" reduces the hazard by around 3.5% versus "erlotinib", with both the 95% confidence intervals based on the proposed asymptotic method and double-resampling method including 1 for hazard ratio, indicating insufficient evidence for a statistically significant difference at 0.05 level in the effectiveness comparison. Among the other adjusted approaches presented in Table 3 , another 95% confidence interval covering 1 for hazard ratio is based on inverse probability weighting. The proposed asymptotic method and double-resampling method for propensity score matching estimator provided wider intervals than other adjusted approaches in Table 3 , while the double-resampling method seemed to be more conservative than the asymptotic results in effectiveness comparison.
Discussion and future studies
We establish the statistical properties of the propensity score matching estimator of the marginal causal hazard ratio based on matching with replacement and a fixed number of matches. We also propose a double-resampling technique for variance estimation that takes into account the uncertainty due to propensity score estimation prior to matching. Several issues are worth discussing. First, although the literature has proposed flexible machine learning methods for estimating the propensity score function, our development relies on a parametric assumption, which enables to quantify the impact of propensity score estimation on the matching estimator. Second, there may not be sufficient overlap in terms of distribution of covariates between treatment groups. Crump et al. (2009) and Yang and Ding (2018) suggested trimming the propensity score beyond some thresholds. The criterion is based on minimizing the asymptotic variance of continuous outcome. It would be interesting to develop similar criteria to identify optimal overlap regions for the survival outcome. Third, Yang et al. (2016) has developed the generalized propensity score matching for multiple treatments for continuous outcomes. It is also of interest to extend our inference framework to more than two treatment comparison for survival outcomes. Fourth, in our future work, we will develop sensitivity analyses to no unmeasured confounding and methods to handle missingness.
Supplementary material
Supplementary material includes proof.
S1 Regularity conditions and Lemmas
In this section, we provide the regularity conditions and lemmas.
Assumption S1 (Regularity conditions). (i) X has a continuous distribution with a compact support and a continuous density function; (ii) µ H (ω, x) is Lipschitz-continuous in x; (iii) E |H i (ω)| 2+δ |W i = ω, X i = x is uniformly bounded over the support of X, for some δ > 0,
The regularity conditions are standard in the literature and are often assumed for technical convenience.
Let n ω = n i=1 I(W i = ω) be the number of individuals received treatment ω, and let p ω = pr(W = ω) > 0, for ω = 0, 1.
Lemma S1. Suppose that (W 1 , X 1 ),...,(W n , X n ) are independent and identically distributed, where X is a scalar continuous variable with a bounded support. Suppose also that σ 2 H (ω, x) is uniformly bounded over the support for X. Then, for a given ω,
Lemma S1 is Lemma A.11 in Abadie and Imbens (2012) .
S2 Proof of the asymptotic unbiasedness of
This section includes three parts that follow the similar logic of proof. The first and the second parts provide some results useful for later sections. The proof for the asymptotic unbiasedness of n −1 S n (β 0 ) is located in the third part.
. From the standard theory for the counting process, dM (ω) (t) is a martingale process with respect to the population and its baseline hazard Λ 0 (t). Next we will prove that I(
} is a martingale for the imputed pseudo-population which means that imputed pseudo-population has similar covariates distribution with the target population. First, we show that for ω = 0, 1,
as n → ∞. We show (S1) for ω = 1. The proof for ω = 0 is similar and therefore omitted. We express (S1) for ω = 1 as
where the second line follows by the consistent assumption, and
Under Assumption S1, Abadie and Imbens (2006) showed that k i (1) δ is bounded almost surely for any δ > 0, and the discrepancy due to matching is |X m{1,e(X i )} −X i | = O p (n −1 ) for a scalar X. It follows that T 1 is consistent for zero. Moreover, assuming that E dM (1) (t) | p is Lipschiz continuous in p, T 2 is consistent for zero. Lastly, by the strong law of large numbers, T 3 is consistent for zero. Therefore, (S1) follows.
Since n
S3 Proof for Theorem 1
Taylor expansion of S n ( β) = 0 around β 0 leads to
whereβ is on the line segment between β and β 0 . Assuming that n −1 ∂S n (β)/∂β T is invertible, we have
Under suitable regularity conditions, n −1 ∂S n (β)/∂β T converges in probability to a positivedefinite matrix A(β 0 ). Then the reminder is to show the asymptotic distribution of n −1/2 S n (β 0 ).
Theorem S1. Suppose Assumptions 1-3 and Assumption S1 hold. Then,
in distribution, as n → ∞, where
Proof. We will show that n −1/2 S n (β 0 ) can be expressed as a sum of n independent and identically distributed random vectors plus a term that converges in probability to a zero vector. By some algebra, we obtain
Therefore, continuing with (S3), we obtain
where (S10) follows from (S8) . Under the standard regularity conditions in survival analysis,
in probability, as n → τ . Therefore, (S11) becomes
where H i (ω) is defined in (11). Moreover,
where the last line follows by the martingale property for the potential outcome process.
We write
Similar to (S2), we have n
, for ω = 0, 1. Therefore, we can write
Consider the σ-fields
is a martingale. Moreover, we evaluate
as n → ∞. Apply the Central Limit Theorem for martingale arrays, (S6) follows.
To establish the result in Theorem 1, we replace X by e(X) as the matching variable; therefore, (S6) holds for
Combining (S5) and (S13), n 1/2 ( β − β 0 ) is asymptotically normal with mean zero and covariance matrix V 1 = A(β 0 ) −1 V S A(β 0 ) −1 . This completes the proof for Theorem 1.
S4 Proof for Theorem 2
Theorem S2. Suppose that Assumptions 1-3 and Assumption S1 hold. Suppose that e(X) follows a logistic regression model e(X T θ) with the true parameter value θ 0 . Letθ be the maximum likelihood estimator for θ, and I θ 0 be the Fisher information matrix. Then, based on matching on the estimated propensity score e(X Tθ ),
Following Abadie and Imbens (2016) , we use the local experiment argument. Let θ n = θ 0 + n −1/2 h, and P θn be the data distribution under e(X T θ n ). Also, we define
Under P θn , we can express
We shall show that under
in distribution, as n → ∞. Then, by Le Cam's third lemma (Le Cam and Yang; 1990) ,
Then, under P θn :
in distribution, as n → ∞.We also note that under P θn :
To show (S15), it suffices to show that
in distribution, as n → ∞. Toward this end, we consider the linear combination
, for any z 1 and z 2 . We write L n = 3n l=1 ξ n,l , where
Consider σ−fields
T 2 cz 1 . Thus, under P θn , (S17) follows. This completes the proof for Theorem 2.
S5 Simulation
S5.1 An data-generating algorithm
We describe the algorithm for generating T (0) and T (1) that are congenial with Model (1) as follows.
Algorithm S1 for generating T (0) and T (1) that are congenial with Model (1)
Step 1. Generate T (0) from S (0) (t) = exp(−λ 0 t), where λ 0 = 4.
Step 2. Generate u from Unif[0, 1], solve
for t, where η 1 = η 2 = −1. Let T (1) be the solution t.
By Algorithm S1, T (1) given X follows
Under our parameter specification, we have
Therefore, the marginal distributions of
S5.2 Illustration of propensity score distributions with weak, medium, and strong separation
This section demonstrates the mentioned simulation settings of weak, medium, strong separations in the propensity scores between the two treatment groups. Density curves for the true propensity scores of the two treatment groups are presented in dashed lines of W = 0 and in solid lines of W = 1 with weak, medium, strong separations respectively in Figure  S1 .
S5.3 Additional simulation results
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Note: "Var" is the variance of point estimates of β 0 across simulated datasets; "VE" is the average variance estimation for the point estimators over simulations, thus VE minus Var reflects the bias in estimated variance; "CR" is the empirical coverage rate of 95% confidence intervals. Four types of variance estimates forβ psm were compared: "software", output from the standard software; "asymp", the proposed asymptotic variance estimation; "naiveboot", the naive nonparametric bootstrap; "double-rsp", the proposed double-resampling method. 
